Alcohol use in opioid agonist treatment
|Title:||Alcohol use in opioid agonist treatment||Authors:||Nolan, Seonaid
|Permanent link:||http://hdl.handle.net/10197/8258||Date:||8-Dec-2016||Abstract:||Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid use disorder individually, less is known about how best to care for those with a dual diagnosis especially since common treatments for opioid addiction may be contraindicated in a setting of alcohol use. This review summarizes existing research and characterizes the prevalence, clinical implications and management of alcohol misuse among individuals with opioid addiction. Furthermore, it highlights clinically relevant management strategies in need of future research to advance care for this unique, but important, patient population.||Funding Details:||European Commission
Irish Research Council
|Type of material:||Journal Article||Publisher:||BioMed Central||Copyright (published version):||2016 the authors||Keywords:||Alcohol use; Alcohol misuse disorder; Opioid agonist treatment; Methadone; Buprenorphine/naloxone||DOI:||10.1186/s13722-016-0065-6||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Medicine Research Collection|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.